Concepedia

Qingyong Li

QL

43

Publications

1.6K

Citations

21

H-Index

2004

Active since

Affiliations

Zhejiang University of Technology(Current)

Northeast Forestry University

Roswell Park Comprehensive Cancer Center

South China University of Technology

Zhejiang Provincial People's Hospital

Qingyong Li is an author at Zhejiang University of Technology specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2004–2023

43

Publications

43

Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?

Fengzhi Li, Tao Jiang, Qingyong Li et al. · PubMed · 2017 · 225 citations · Full text

, , +14

Moderation of hyperuricemia in rats <i>via</i> consuming walnut protein hydrolysate diet and identification of new antihyperuricemic peptides

Qingyong Li, Xiaoyan Kang, Chuanchao Shi et al. · Food & Function · 2017 · 109 citations

Microwave‐Assisted Degradation of Polysaccharide from <i>Polygonatum sibiricum</i> and Antioxidant Activity

Hui Zhang, Xiu‐ting Cai, Qinghua Tian et al. · Journal of Food Science · 2019 · 90 citations

Anti-hyperuricemic peptides derived from bonito hydrolysates based on in vivo hyperuricemic model and in vitro xanthine oxidase inhibitory activity

Yujuan Li, Xiaoyan Kang, Qingyong Li et al. · Peptides · 2018 · 88 citations

, , +5

Preparation and characterization of camptothecin powder micronized by a supercritical antisolvent (SAS) process

Xiuhua Zhao, Yuangang Zu, Qingyong Li et al. · The Journal of Supercritical Fluids · 2009 · 77 citations

, , +7

Rows per page

1–5 of 43